Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Actigraphy Device Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11038| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Actigraphy Device Market size was more than USD 4.2 billion in 2026 and is set to grow at a 24.8% CAGR between 2027 and 2036, surpassing USD 38.49 billion by 2036. The industry revenue for 2027 is calculated at USD 5.08 billion.

Base Year Value (2026)
USD 4.2 billion
CAGR (2027-2036)
24.8%
Forecast Year Value (2036)
USD 38.49 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Actigraphy Device Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads with 37.91% share due to established sleep and behavioral health monitoring, widespread wearable diagnostic use, and strong integration into clinical research and long-term patient tracking.
  • Asia Pacific growth is driven by rapid adoption of wearable health technologies, expanding digital health access, rising sleep disorder awareness, and use of non-invasive remote monitoring devices, at 27.83% CAGR.

Segment Momentum

  • Healthcare providers lead the market because they prescribe, interpret, and integrate actigraphy data into clinical assessment, supporting established workflows for sleep evaluation and activity monitoring.
  • Chronic disease management is the fastest-growing application as continuous monitoring of daily activity and sleep patterns increasingly supports long-term patient management and remote care decisions.

Market Expansion Drivers

  • Rising prevalence of sleep disorders increasing demand for continuous sleep monitoring devices.
  • Growing aging population accelerating adoption of non-invasive sleep assessment technologies.
  • Expanding awareness of sleep health supporting personalized digital health monitoring adoption.

Leading Market Participants

  • Leading companies in the actigraphy device market include Koninklijke Philips N.V. (Netherlands), ActiGraph, LLC (United States), Empatica Inc. (United States), CamNtech Ltd. (United Kingdom), Fibion Inc. (Finland), ActivInsights Ltd. (United Kingdom), neurocare group AG (Germany), Garmin Ltd. (Switzerland), Fitbit LLC (United States), Withings S.A. (France).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 4.2 billion
  • 2027 Estimated Market Size: USD 5.08 billion.
  • Projected Market Size: USD 38.49 billion by 2036
  • Growth Forecast: 24.8% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Sleep Disorders (Application) | Healthcare Providers (End Use)
  • Emerging Opportunity Segment: Chronic Disease Management (Application) | Homecare Settings (End Use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of sleep disorders increasing demand for continuous sleep monitoring devices

The increasing prevalence of sleep disorders is creating a stronger need for accessible and continuous monitoring solutions, which will drive the actigraphy device market growth. Actigraphy devices enable prolonged observation of sleep-wake patterns through non-invasive monitoring, helping healthcare professionals and individuals identify irregular sleep behaviors and assess changes over time. Their ability to support monitoring outside clinical settings also makes them useful for repeated assessments, sleep management, and longitudinal observation, particularly where conventional sleep evaluation methods may be less convenient.

Growing aging population accelerating adoption of non-invasive sleep assessment technologies

As the global aging population expands, the need for convenient approaches to monitor age-related changes in sleep patterns is increasing, supporting the actigraphy device market. Older adults commonly require closer observation of sleep quality and daily activity rhythms, creating demand for technologies that can collect information without invasive procedures or prolonged clinical intervention. Actigraphy-based monitoring can facilitate routine assessment in home and care settings while providing continuous behavioral and sleep-related information that can assist healthcare professionals in evaluating changing sleep patterns.

Expanding awareness of sleep health supporting personalized digital health monitoring adoption

Greater awareness of sleep health is encouraging individuals to take a more proactive approach to understanding and managing their sleep patterns, thereby boosting the actigraphy device market demand. Consumers and healthcare providers are increasingly interested in digital monitoring technologies that provide individualized insights into activity and sleep cycles and can support ongoing wellness management. The availability of wearable and connected monitoring approaches also enables sleep-related information to be incorporated into personalized health routines, encouraging broader use of non-invasive digital assessment technologies.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of sleep disorders increasing demand for continuous sleep monitoring devices 2.00% Moderate North America, Europe High Near Term
Growing aging population accelerating adoption of non-invasive sleep assessment technologies 1.80% Moderate North America, Asia Pacific High Mid Term
Expanding awareness of sleep health supporting personalized digital health monitoring adoption 1.50% Moderate North America, Europe Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Actigraphy Device Market
Largest Region
North America
37.91% Market Share in 2026

North America (Largest Region)

In the actigraphy device market, North America held the largest share in 2026, accounting for 37.91% share, supported by advanced healthcare infrastructure, strong adoption of digital health technologies, and growing use of objective monitoring tools in sleep and circadian rhythm assessment. The region benefits from established clinical research capabilities and increasing awareness of sleep-related disorders, encouraging healthcare providers and researchers to incorporate wearable actigraphy devices into diagnostic and monitoring workflows. Rising demand for remote patient monitoring and convenient, non-invasive assessment solutions is also strengthening adoption, while technological improvements in wearable sensors, data analytics, and connectivity are broadening the practical applications of actigraphy across healthcare and research settings.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is experiencing the fastest growth, driven by expanding healthcare infrastructure, increasing awareness of sleep health, and greater adoption of wearable and connected medical technologies. Growing urbanization and changing lifestyles are contributing to increased attention toward sleep quality and circadian health, creating opportunities for actigraphy-based monitoring solutions. Improvements in access to specialized healthcare and diagnostic services are further supporting demand, while the expansion of digital health ecosystems is making wearable monitoring technologies more accessible. Increasing clinical and research activity related to sleep disorders is also expected to reinforce the region's adoption of actigraphy devices.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Research-Driven Diagnostics

Germany emphasizes actigraphy devices that deliver reliable long-term activity and sleep monitoring for clinical and academic applications. Organizations in Germany focus on validated measurement performance and integration with established diagnostic workflows.

France 🇫🇷

Sleep Research Applications

France focuses on actigraphy devices that support sleep medicine, behavioral research, and long-term patient observation. Clinical users in France prioritize dependable monitoring solutions that complement laboratory assessments and outpatient care programs.

Italy 🇮🇹

Ambulatory Monitoring Support

Italy utilizes actigraphy devices to strengthen ambulatory sleep assessment and routine patient follow-up outside hospital environments. Healthcare professionals in Italy increasingly adopt user-friendly wearable solutions that improve longitudinal monitoring and clinical workflow efficiency.

Japan 🇯🇵

Compact Wearable Assessment

Japan prioritizes compact actigraphy devices that provide continuous monitoring with minimal disruption to daily routines. Healthcare institutions in Japan increasingly value accurate data collection and user comfort for sleep and circadian rhythm evaluation.

South Korea 🇰🇷

Digital Health Integration

South Korea advances the use of actigraphy devices through connected healthcare ecosystems and wearable technology adoption. Providers in South Korea emphasize seamless data sharing, remote monitoring capabilities, and efficient patient engagement across clinical settings.

United States 🇺🇸

Clinical Sleep Monitoring

The U.S. actigraphy device market prioritizes wearable monitoring solutions for sleep assessment, clinical research, and remote patient management. Healthcare providers in the U.S. increasingly integrate actigraphy data into digital health platforms to support evidence-based care decisions.

Segment Analysis

Segment Leadership and Growth Trends

Actigraphy Device Market Share (%), by Application, 2026

Sleep Disorders
Physical Activity Monitoring
Chronic Disease Management

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Application Segment Analysis: Sleep Disorders (Largest Segment) vs Chronic Disease Management (Fastest-Growing Segment)

The sleep disorders segment represented the largest share of the actigraphy device market in 2026, driven by the growing use of objective sleep and activity measurements to support the assessment of sleep patterns and circadian rhythms. Actigraphy provides a practical means of collecting continuous behavioral data outside conventional clinical environments, making it valuable for evaluating sleep quality and identifying irregular sleep-wake patterns. Increasing awareness of sleep health and the need for longitudinal monitoring are reinforcing adoption among healthcare professionals and specialized sleep-care settings.

Chronic disease management is the fastest-growing application segment as actigraphy expands beyond dedicated sleep assessment into broader monitoring of activity patterns, rest cycles, and patient behavior. Chronic conditions often require ongoing observation of lifestyle and functional changes, creating demand for wearable approaches that can provide continuous information without imposing substantial disruption on daily routines. The growing emphasis on remote monitoring, personalized care, and preventive management is broadening the clinical relevance of actigraphy devices.

End Use Segment Analysis: Healthcare Providers (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)

Healthcare providers held the largest share of the actigraphy device market in 2026, reflecting the central role of hospitals, clinics, and specialist practices in diagnosing sleep-related conditions and interpreting patient activity data. These settings benefit from professional expertise needed to integrate actigraphy results with clinical assessments and treatment decisions. Wider adoption of objective monitoring tools in routine care is strengthening the position of healthcare providers as an important end-use group.

Homecare settings are experiencing the fastest growth as healthcare delivery increasingly shifts toward patient monitoring outside conventional clinical facilities. Actigraphy devices can capture sleep and activity information during normal daily routines, supporting convenient observation while reducing the need for repeated in-person assessments. The expansion of remote care models, growing patient preference for home-based monitoring, and increased focus on continuous health management are creating stronger demand for actigraphy solutions in residential environments.

Segment Sub-Segment Largest Segment Fastest Growing
Application Sleep Disorders, Physical Activity Monitoring, Chronic Disease Management Sleep Disorders Chronic Disease Management
End Use Healthcare Providers, Research Institutions, Homecare Settings, Fitness and Sports Centers Healthcare Providers Homecare Settings
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the actigraphy device market:

1. Koninklijke Philips N.V. (Netherlands)

2. ActiGraph LLC (United States)

3. Empatica Inc. (United States)

4. CamNtech Ltd. (United Kingdom)

5. Fibion Inc. (Finland)

6. ActivInsights Ltd. (United Kingdom)

7. neurocare group AG (Germany)

8. Garmin Ltd. (Switzerland)

9. Fitbit LLC (United States)

10. Withings S.A. (France)

The competitive dynamics of the actigraphy device market are increasingly shaped by advancements in digital health monitoring and wearable integration. Market participants are prioritizing the development of compact, data-driven solutions capable of delivering improved sleep and activity tracking accuracy. Rising demand for remote patient monitoring has also accelerated investments in sensor innovation, mobile connectivity, and analytics platforms. Alongside these developments, continuous R&D efforts are supporting the launch of user-friendly devices tailored for both clinical and consumer wellness applications, strengthening innovation intensity across the market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Koninklijke Philips N.V. (Netherlands)
ActiGraph LLC (United States)
Empatica Inc. (United States)
CamNtech Ltd. (United Kingdom)
Fibion Inc. (Finland)
ActivInsights Ltd. (United Kingdom)
neurocare group AG (Germany)
Garmin Ltd. (Switzerland)
Fitbit LLC (United States)
Withings S.A. (France).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Actigraphy Device Market — Custom Segments

Segment Sub-Segment
Device Form Factor Wrist-Worn Devices, Ankle-Worn Devices, Chest-Worn Devices, Bedside/Non-Wearable Devices
Connectivity Bluetooth-Enabled, Wi-Fi-Enabled, Cellular-Enabled, USB/Offline Data Transfer
Procurement Model Direct Purchase, Institutional Procurement, Subscription-Based Models, Device Rental/Leasing

Actigraphy Device Market — Custom TOC

Custom Chapter Custom Details
Clinical Adoption Pathway Assessment
  • Clinical Use Cases and Adoption Drivers
  • Evidence Requirements and Clinical Validation Priorities
  • Integration into Sleep and Patient Monitoring Pathways
  • Adoption Barriers Across Healthcare Settings
  • Clinical Deployment Opportunities
Digital Health Integration Landscape
  • Integration with Digital Health Platforms and Connected Care Ecosystems
  • Data Interoperability and Workflow Integration
  • Remote Monitoring and Digital Patient Engagement Models
  • Analytics-Enabled Clinical Applications
  • Strategic Integration Priorities
Home-Based Patient Monitoring Opportunities
  • Shift Toward Home-Based Sleep and Patient Monitoring
  • At-Home Monitoring Use Cases and Patient Cohorts
  • Device Deployment Models and Care Pathway Integration
  • Provider and Patient Adoption Considerations
  • Emerging Opportunities in Decentralized Monitoring

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current revenue of the actigraphy device market?

In 2027 the market for actigraphy device is worth approximately USD 5.08 billion.

What are the growth projections for the actigraphy device industry?

Actigraphy Device Market size was more than USD 4.2 billion in 2026 and is set to grow at a 24.8% CAGR between 2027 and 2036, surpassing USD 38.49 billion by 2036.

How is demand for continuous sleep monitoring accelerating adoption of actigraphy devices?

Growing interest in longitudinal sleep data is increasing adoption among healthcare providers, research institutions, and digital health platforms seeking scalable monitoring solutions for screening, follow-up, and treatment evaluation.

Why are non-invasive sleep assessment technologies gaining importance in aging care pathways?

Easy-to-use actigraphy systems support repeated monitoring for older adults, influencing procurement toward comfortable, compliant solutions that integrate with broader home care and health management models.

Why are healthcare providers the largest end users in the actigraphy device market?

Healthcare providers lead the market because they prescribe, interpret, and integrate actigraphy data into clinical assessment, supporting established workflows for sleep evaluation and activity monitoring.

Why is chronic disease management the fastest-growing application in the actigraphy device market?

Chronic disease management is the fastest-growing application as continuous monitoring of daily activity and sleep patterns increasingly supports long-term patient management and remote care decisions.

Why does North America lead the actigraphy device market?

North America leads with 37.91% share due to established sleep and behavioral health monitoring, widespread wearable diagnostic use, and strong integration into clinical research and long-term patient tracking.

What is driving growth in Asia Pacific actigraphy device market?

Asia Pacific growth is driven by rapid adoption of wearable health technologies, expanding digital health access, rising sleep disorder awareness, and use of non-invasive remote monitoring devices, at 27.83% CAGR.

Which companies are driving growth in the actigraphy device landscape?

Leading companies in the actigraphy device market include Koninklijke Philips N.V. (Netherlands), ActiGraph, LLC (United States), Empatica Inc. (United States), CamNtech Ltd. (United Kingdom), Fibion Inc. (Finland), ActivInsights Ltd. (United Kingdom), neurocare group AG (Germany), Garmin Ltd. (Switzerland), Fitbit LLC (United States), Withings S.A. (France).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →